Therapeutic targeting of FLT3 and associated drug resistance in acute myeloid leukemia
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Gebru, Melat T.
Text and Data Mining valid from 2020-11-19
Version of Record valid from 2020-11-19
6 October 2020
3 November 2020
19 November 2020
Ethics approval and consent to participate
The authors declare no competing interests.